PLSE
Pulse Biosciences, Inc.
Industry
Medical - Instruments & Supplies
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Loading...
Open
17.29
Mkt cap
1.1B
Volume
146K
High
17.72
P/E Ratio
-21.27
52-wk high
22.69
Low
16.80
Div yield
N/A
52-wk low
6.59

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.